Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
IDARUCIZUMAB 2.5 GM/50ML IV SOLN (NDC 00597019705) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 17, 2026 , from http://ppman.hank.ai/transparency/procedure/00597019705/by-state?code_type=NDC
“IDARUCIZUMAB 2.5 GM/50ML IV SOLN (NDC 00597019705) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/00597019705/by-state?code_type=NDC. Accessed
October 17, 2026 .
“IDARUCIZUMAB 2.5 GM/50ML IV SOLN (NDC 00597019705) by State,” HANK Price Transparency ,
accessed October 17, 2026 ,
http://ppman.hank.ai/transparency/procedure/00597019705/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
00597019705 — Idarucizumab 2.5 Gm/50ml IV Soln
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$2,948
National median
$676 – $5,126
IQR (p25 – p75)
38
hospitals filing
12
states
Walking in without insurance?
Cash / self-pay price
Cash median
$4,027
vs. negotiated
+36.6%
Hospitals reporting
41
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 00597019705 (NDC), with interquartile range
State Median p25 p75
VT $5,446 $3,457 $5,729
MD $5,299 $5,299 $5,299
CA $5,126 $4,723 $5,858
NJ $4,980 $2,747 $5,910
OH $4,422 $3,782 $5,236
MI $3,951 $3,174 $4,934
IN $2,948 $2,948 $2,948
HI $1,975 $1,967 $5,060
AL $1,531 $292 $1,845
NY $1,206 $1,206 $1,206
OR $8 $4 $9
FL $3 $2 $4,943